The Secret of Great Health Care
Pneumonia
Pneumonia is an inflammation in the interstitium of the lung or alveoli caused by microorganisms. It is one of the most common causes of death due to infectious disease.
Pneumonia can be acquired in the home, community or hospital. Bacteria cause many cases of pneumonia and common causative agents include: Streptococcus pneumoniae, Haemophilus influenza, Moraxella catarrhalis, Staphylococcus aureus, Klebsiella pneumonia, Chlamydia and Mycoplasma. Viral agents are sometimes responsible for pneumonia and include agents such as influenza virus, adenovirus, para influenza and respiratory syncytial virus (RSV).
The most common organism that causes pneumonia is Streptococcus pneumoniae, treatment should be selected considering this pathogen. S pneumoniae typically lives pharynx and is carried by about 50 percent of the population.
This section will focus primarily on community-acquired pneumonia (CAP)
Risk Factors
Certain factors increase the risk of getting pneumonia. In addition, specific patients are more prone to specific types of pneumonia. Older patients are more likely to get pneumonia than their younger counterpart.
Those with chronic obstructive pulmonary disease (COPD) are more likely to get pneumonia and Haemophilus pneumoniae is most common in this group. Those who abuse alcohol are most likely to come down with Klebsiella pneumoniae. Younger adults who come down with pneumonia are more likely to be afflicted with an atypical organism such as Mycoplasma pneumoniae or Chlamydia pneumoniae. C. pneumoniae is responsible for 2-5% of all CAP pneumonia. Those who are exposed to air-conditioning or aerosolized water are most likely to be afflicted with Legionella pneumoniae. Children under the age of two are most likely to get pneumonia from viruses. Diabetics – especially if diabetic ketoacidosis is present – are more likely to be afflicted with Streptococcus pneumoniae or Staphylococcus aureus. HIV infections increases the risk of many unusually pneumonias. Signs and Symptoms
A good history will help the clinician determine which type of organism is likely affecting the patient. Signs and symptoms can be variable depending on the severity and the organism affecting the patient. The disease often starts with the onset of productive cough or purulent sputum, shortness of breath, tachycardia, pleuritic chest pain, fever and chills. The symptoms come on over a 1 to 10 hour period.
The exam typically shows abnormal lung sounds including focal crackles over the area of consolidation. In addition, dullness to percussion may be noted or egophony.
Different organisms may have different presentations. Streptococcus pneumoniae is characterized by rigors, rust-colored sputum and pleuritic chest pain. Legionella pneumoniae presents with systemic systems such as diarrhea, hyonatremia and these patients typically have underlying cardiac or respiratory chronic disease. Green sputum may be indicative of Pseudomonas or Haemophilus. Foul smelling sputum suggests an anaerobic infection. Chlamydia pneumoniae presents with a long prodrome, sore throat and a hoarse voice. Klebsiella pneumoniae typically occurs in those with chronic illness and alcoholism and presents with currant jelly sputum.
Other symptoms that may be present include: headache, diarrhea, nausea, vomiting and malaise, which are more common with atypical organisms.
Travel history or location of the patient also helps gives clues to the type of pneumonia. Blastomyces dermatitidis is more common in the Midwest United States, Coccidioides immitis is more common in the Southwest United States.
Animals can pass on certain types of infections. Exposure to cattle, goats or sheep may increase the risk Coxiella burnetii. Chlamydia psittaci transmission can occur with contact to ducks, chickens or turkeys. More uncommon causes of atypical pneumonia also present with atypical signs or symptoms. This includes tularemia where the patient had close contact with a deer or rabbit or was bitten by a tick or deer fly. Q fever may occur if there is close contact with a sheep or parturient cat. Psittacosis is caused by an organism form a psittacine bird. These patients may present with headache, myalgia, rash, pharyngitis, relative bradycardia, splenomegaly or cardiac involvement.
Many disease states increase the risk of certain types of pneumonias. Once a complete history is taken a physical exam can help in the diagnosis and treatment of pneumonia. Common findings include:
Other findings on the exam can help the clinician determine the etiology of the infection. Bullous myringitis indicates possible Mycoplasma pneumoniae. Aspiration pneumonia is indicated by a patient without a gag reflex, recent seizure activity or change in mental status. Significant periodontal disease with foul smelling sputum indicates possible anaerobic pneumonia.
Atypical pneumonias are more likely to present with extrapulmonary finding. Mycoplasma pneumonia may present with myalgia, ear pain, mental confusion, diarrhea, rash, and nonexudative pharyngitis. Legionnaires disease may present with myalgia, confusion, pleuritic chest pain, diarrhea, abdominal pain, relative bradycardia and hemoptysis. Chlamydia pneumonia may present with nonexudative pharyngitis, headache or stiff neck.
Diagnosis
Most cases of pneumonia are diagnosed on clinical exam with a confirmatory chest x-ray. Different type of infections can appear differently on x-ray. Streptococcus pneumonia may show segmental or lobar opacity, possibly with air bronchogram. Focal opacity is seen in many different types of pneumonias. Klebsiella often affects the upper lungs while Legionella affects the lower lungs. Staphylococcus aureus as well as gram negative infections and anaerobic infections may present with cavitation and pleural effusion. M pneumoniae may present with an interstitial pattern.
Some patients may have a clear chest x-ray, but pneumonia is still suspected due to the patient’s clinical appearance. In this situation the use of a CAT scan may help diagnose pneumonia.
Blood work is done in more severe cases. A complete blood count will often show an elevated white blood cell count with a left shift. Leukopenia is a poor prognostic sign and may indicate impending sepsis. When patients are extremely sick blood cultures may be performed, but do not have a high yield as they are positive in about 40% of the cases.
Some patients have a sputum culture. Sputum examination provides an accurate diagnosis in approximately 50% of patients. A good specimen will have fewer than 10 squamous epithelial cells and more than 25 WBCs per low-power field. In some neutropenic patients there may be less than 25 white blood cells per low-power field despite infection in the lower respiratory tract. When gram stain demonstrates a single organism pneumonia is likely as opposed to when multiple organisms are present, which likely represents a contaminated specimen.
Based on clinically history and exam it is important to determine which organism is most likely causing the infection. Identifying the likely organism is important as it can mean the difference between treatment failure and success.
Atypical pneumonia presents "atypically". Features may include a low grade fever, mild, non-productive cough with body aches and fatigue. The presentation can be very similar to a viral infection. Legionella is associated with high fever and shortness of breath. Organisms that make up the atypical class include: Mycoplasma pneumoniae (the most common cause), Chlamydia pneumoniae, Legionella and Moraxella. The atypical pneumonias are less common than typical pneumonias, harder to diagnose, and are resistant to some antibiotics – such as beta-lactams. Legionella is diagnosed with direct fluorescent antibody or indirect fluorescent antibody; unfortunately this test has a high rate of false negative tests. A urine antigen for Legionella can be used with good accuracy.
Blood work to detect immunoglobulin M antibodies aid in the diagnosis of Mycoplasma and Chlamydia pneumonia. Likewise serology is essential in diagnosing unusual causes of pneumonia such as brucellosis and Q fever.
Culture of the sputum is typically not helpful and in the complete blood count the white blood cell count may be only mildly elevated. The chest x-ray can be variable showing a unilateral lower infiltrate or diffuse infiltrates.
If pleural effusion – particularly a parapneumonic pleural effusion- is present, thorocentesis should ensue. The fluid should be cultured and gram stained. Diagnostic testing can help determine if there is a complicated or simple effusion.
In some cases arterial blood gases are drawn which can help determine the severity of the infection and the need for supplemental oxygen. ABGs are indicated in all patients with a pulse oximetry reading of less than 90% or any other signs of hypoxia.
In severe or complicated cases of pneumonia bronchoscopy is performed which can help attain cultures to more definitively determine the causative organism.
For outpatient CAP the use of diagnostic tests is recommended if it is going to change the treatment plan. For CAP patients who were admitted to the hospital for management, blood cultures are likely not helpful as they lead to antibiotic narrowing in between zero and three percent of patients.
Treatment
Ninety percent of those with bacterial pneumonia who receive empiric treatment will improve. The first factor to determine in the treatment of patients is where the patient is going to be treated: outpatient or inpatient. Young healthy patients without acute distress are safely treated as outpatients. Hospitalization is indicated for patients who are sicker. It is essential that the clinician consider other co-morbid conditions as well as the severity of the illness upon initial presentation when considering where to treat the patient. Those who have multi-lobular infection, neutropenia or poor host resistance may need hospitalization. Patients with altered mental status and abnormal vital signs may need inpatient management.
While these are general rules, there is a scoring system that has been developed. The patient is classified into one of four categories.
Category 1: Community acquired pneumonia (CAP), less than 60 years old, no major medical co-morbidities
Category 2: Community acquired pneumonia with medial co-morbidities and/or over the age of 60 – with mild disease – able to be treated out of the hospital
Category 3: CAP that necessitates the hospital
Category 4: CAP that necessitates the ICU.
Inpatient care is much more expensive, costing the health care system 25 times more than outpatient care. One method to determine who is a candidate to be admitted to the hospital is using the CURB-65 scale. This looks at five parameters of the patient and if 2 or more are positive then the patient should be admitted to the hospital. While this is easy to remember it is not well studied.
|
C- confusion U – uremia (BUN greater than 20 mg/dl) R – respiratory rate (greater than 30 per minute) B – low blood pressure (systolic less than 90 mm Hg or diastolic less than or equal to 60 mm Hg) 65 – over the age of 65 |
Table 2Mortality Rate based on CURB-65 Score
|
Score on the CURB-65 |
30 Day mortality rate (in percentage) |
|
0 |
0.7 |
|
1 |
2.1 |
|
2 |
9.2 |
|
3 |
14.5 |
|
4 |
40 |
|
5 |
57 |
Patients with a score of 0 or one can be treated as outpatients those with 2 should be admitted to a general medical unit and those with a score greater than 3 should be admitted to the intensive care unit.
Another method often used in the PSI method. This places patients into 5 classes. Class 1 and 2 should be treated as outpatients, 3 should be treated with a short hospitalization or an observation stay, class 4 and five should be inpatients. This is less useful clinically as it requires evaluating 20 variables and is more difficult to use.
Certain factors, if present, necessitate hospitalization even if CURB-65 or PSI scores do not recommend hospitalization. These include: an arterial oxygen saturation of less than 90% or a partial pressure of oxygen less than 60 mm Hg, individuals who are excessively vomiting, have cognitive dysfunction, have severe mental illness, poor functional capacity, injection drug use or are unable to care for themselves at home.
When deciding to hospitalize the patient or not, it is important to consider other co-morbid factors. Pneumonia has the potential to exacerbate many other disease states such as COPD, heart failure, renal failure or diabetes.
Based on the most likely causative organism initial antibiotics should be prescribed. The most likely organisms in those patients with pneumonia who are younger than 60, without medical co-morbidities, who are going to be managed as outpatients are S pneumoniae, M pneumoniae, C pneumoniae, H influenzae, Legionella species and S aureus. Macrolide antibiotics are the first-line choice for antibiotics and a second choice is doxycycline.
Those individuals who are not sick enough to be admitted to the hospital, but have co-morbidity and are over the age of 60 have pneumonia most likely caused by: S pneumoniae, H influenzae, Aerobic gram-negative bacilli, S aureus, M catarrhalis, Legionella species or Mycoplasma.
For the patient with a co-morbidity such as chronic lung, liver, heart or renal disease, diabetes, alcoholism, asplenia, cancer or a condition that suppresses the immune system or if they have been on an antibiotic in the last 3 months should be treated with a respiratory quinolone or a beta-lactam (high dose amoxicillin, amoxicillin/clavulanate or a higher generation cephalosporin) and a macrolide (doxycycline as an alternative). Caution must be implemented in areas where there is a high degree of macrolide resistance and the use of a quinolone should be considered.
Recent research compared the use of levofloxacin 750 mg a day against ceftriaxone 1 gram plus azithromycin 500 mg a day in CAP. The levofloxacin group had a lower length of stay and a shorter period of time in which they required intravenous antibiotics. Another study compared levofloxacin 750 mg IV to moxifloxacin 400 mg IV and the levofloxacin resulted in a reduced length of stay, but no difference in the percent of complications.
One notable side effect of the quinolones is their risk of tendon rupture. It most commonly occurs in the Achilles tendon, but could occur in any tendon. This is more common in individuals over 60 years old and those on corticosteroids.
When micro aspiration is suspected the use of Beta-lactam/Beta-lactamase inhibitors, clindamycin or a carbapenem should be considered.
Patients sick enough to be admitted to the hospital could be afflicted with S pneumoniae, H influenzae, polymicrobial (including aerobic bacteria) infection, Aerobic gram-negative bacilli, Legionella species, S aureus, C pneumoniae, M pneumoniae or M catarrhalis. The first choice is a respiratory quinolone or a beta-lactam (ceftriaxone, cefotaxime, ampicillin) and a macrolide (with doxycycline as a back-up).
Atypical pneumonia is treated with antibiotics and supportive care. Medications from the macrolide class are commonly chosen as they cover Mycoplasma pneumonia and Legionella.
Supportive care includes: rest, analgesics/antipyretics, fluids and cough suppressants.
Certain factors dictate the need to hospitalize a patient. The following risk factors predict higher death rates and a more complicated course: older than 65 years old or co-morbid illness such as COPD, diabetes, heart failure, alcoholism, chronic liver disease, aspiration or post-splenectomy. Certain findings on physical exam also predict a worse outcome such as a respiratory rate greater than 30 breaths per minute or a temperature greater than 101 degrees Fahrenheit, blood pressure less than 90/60 mm Hg and altered mental status. Certain laboratory characteristics also predict a poor outcome. A white blood cell count of less than 4000 cells/ml or greater than 30,000 cells/ ml; a PaO2 on ABG of less than 60 mm Hg or a PaCO2 of greater than 50 mm Hg on room air; renal failure with a serum creatinine of greater than 1.2 mg/dl or blood urea nitrogen of greater than 20 mg/dl; metabolic acidosis; increased prothrombin time (PT), increased partial thromboplastin time (PTT) or decreased platelets predict poor outcome. A chest x-ray that shows multiple lobes involved, a rapidly progressive pneumonia, pleural effusion or a cavity also predicts a poor outcome. Social factors should also be considered when deciding to treat the patient at home or in the hospital. Those without a reliable caregiver at home should be considered for inpatient management. The Pneumonia Severity of Illness Scoring System (PSISS) utilizes all of these tools in a scoring system that looks at 20 different clinical features that can be used to determine the place of treatment. The tool assigns points for given characteristics. One point is assigned for each year in age with women subtracting 10 points. Nursing home residents add 10 points. Points are assigned for co-morbid conditions: 30 points for cancer, 20 points for liver disease and 10 points for congestive heart failure, cerebrovascular disease and renal disease. Physical exam findings are also assigned points: 20 points are added for altered mental status, respiratory rate greater than 30, systolic blood pressure less than 90 mm Hg; 15 points for temperature below 95 degrees Fahrenheit or greater than 104 degrees Fahrenheit; 10 points for a heart rate greater than 125 beats per minute. Laboratory evaluation is also given point totals: arterial pH of less than 7.35 is assigned 30 points, blood urea nitrogen of greater than 30 mg/dl and sodium less than 130 mmol/L is assigned 20 points; 10 points is given for glucose greater than 250 mg/dl, hematocrit less than 30%, PaO2 less than 60 mm Hg and pleural effusion. Based on this system the patient is classified into five categories. Class I: less than 50 years old, no co morbid illness and stable vital signs; Class II: less than 70 points; Class III: 71-90 points; Class IV: 91-130; Class V: more than 131 points. Those in class I and II are candidates for treatment at home. Class III should be evaluated in the emergency room. Class IV and V typically require hospital admission. The patient should be watched closely for the first 48-72 hours. Treatment should be maintained during this time, unless the patient clinically deteriorates. Patients who do not improve by 72 hours should be reevaluated. The patient should be looked at for an antibiotic that is not covering the organism, drug resistance, a complication such as an abscess that has set in or if there was an incorrect diagnosis. Clinically the patient may cough for beyond a week even with adequate treatment. In pneumococcal pneumonia, cough takes about 8 days to clear and crackles may persist for about 3 weeks. It takes between 4-12 weeks until the chest x-ray clears. Outpatients should have a follow up chest x-ray in about 6 weeks. Younger patients tend to clear quicker than older patients. Prevention Vaccination is a primary mode to prevent pneumonia. It is extremely important that high risk patients are vaccinated including those with multiple medical co-morbidities. Vaccination should occur against influenza as well as pneumococcus. The pneumococcal vaccine is the 23-valent vaccine and is helpful to prevent invasive pneumococcal disease. Nosocomial pneumonia also can be prevented. Vaccination is important, but other factors are critical. Staff hand washing is a key step in preventing the spread of not just pneumonia but many other nosocomial infections. Good nursing care is important to prevent infection. Providing good nutrition, ambulating patients and proper handling of ventilator tubing all decreases the risk of nosocomial pneumonia. Complications from pneumonia Pneumonia can lead to much morbidity and mortality and being aware of complications is a critical nursing measure. Common complications include: lung abscess, respiratory failure, chronic ventilator dependence, bronchiectasis, necrotizing pneumonia, empyema, superinfection, and drug resistance. Prognosis Most cases of pneumonia, especially in healthy patients, have a good outcome with complete resolution without any residual problems. Those with advanced age, multiple co-morbidities or severe disease are at risk for morbidity and mortality.